Filtered By:
Specialty: International Medicine & Public Health
Condition: Heart Failure
This page shows you your search results in order of date.
Order by Relevance | Date
Total 150 results found since Jan 2013.
Use of hospital services by patients with chronic conditions in sub-Saharan Africa: a systematic review and meta-analysis
CONCLUSION: Among patients seeking hospital care in sub-Saharan Africa, multimorbidity remains poorly described despite high burdens of individual chronic diseases. Prospective public health studies of multimorbidity burden are needed to generate integrated and context-specific health system interventions that act to maximize patient survival and well-being.PMID:37638357 | PMC:PMC10452942 | DOI:10.2471/BLT.22.289597
Source: Bulletin of the World Health Organization - August 28, 2023 Category: International Medicine & Public Health Authors: Stephen A Spencer Jamie Rylance Jennifer K Quint Stephen B Gordon Paul Dark Ben Morton Source Type: research
EE230 Clinical and Economic Outcomes Associated With Use of Anti-Arrhythmic Drugs Versus Ablation in Atrial Fibrillation (AFib)
This study evaluates the clinical and economic benefits of rhythm control with AADs or ablation.
Source: Value in Health - December 1, 2022 Category: International Medicine & Public Health Authors: J Ken-Opurum, P Vadagam, L Faith, SSS Srinivas, R Preblick, S Park, S Charland, A Revel Source Type: research
Prevalence of Cardiovascular Diseases Among Breast Cancer Survivors: Findings From the NHANES 2003-2018
CONCLUSION: Our findings suggest that BC survivors are at risk of suffering from CVD and public health strategies for the long-term management of CVD risk factors in this vulnerable population group is recommended.PMID:35975972 | DOI:10.1177/08901171221120910
Source: American Journal of Health Promotion : AJHP - August 17, 2022 Category: International Medicine & Public Health Authors: Youngdeok Kim R Lee Franco Alexander R Lucas Arnethea L Sutton Jessica G LaRose Jonathan Kenyon Jeremy Via Richard K Cheng Ralph B D'Agostino Vanessa B Sheppard W Gregory Hundley Source Type: research
EE352 Projecting the Incidence and Costs of Major Cardiorenal Complications of Type 2 Diabetes with Widespread GLP-1 RA and SGLT2I Use
Whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) or sodium-glucose co-transporter 2 inhibitors (SGLT2is) are cost-effective when considering solely their cardiorenal benefits is unknown. We projected the incidence and costs of hospitalisation for myocardial infarction (MI), stroke, and heart failure (HF), and end-stage kidney disease (ESKD) among people with type 2 diabetes under scenarios of widespread use of these drugs, from an Australian healthcare perspective.
Source: Value in Health - June 26, 2022 Category: International Medicine & Public Health Authors: J Morton, C Marquina, JE Shaw, D Liew, Z Ademi, D Magliano Source Type: research
Red meat consumption, incident cardiovascular disease, and the influence of dietary quality in the Jackson Heart Study
CONCLUSIONS: In this cohort of African American adults, total and processed meat were not associated with CVD outcomes, with the exception that unprocessed red meat was related to greater stroke risk. Dietary quality did not modfiy these associations. Research is needed in similar cohorts with longer follow-up and greater meat consumption to replicate these findings.PMID:35733368 | DOI:10.1017/S1368980022001434
Source: Public Health Nutrition - June 23, 2022 Category: International Medicine & Public Health Authors: Sherman J Bigornia Sabrina E Noel Caitlin Porter Xiyuan Zhang Sameera A Talegawker Teresa C Carithers Adolfo Correa Katherine L Tucker Source Type: research
Changes in glycaemic control of oral anti-diabetic medications assessed by continuous glucose monitors among patients with type 2 diabetes: a protocol of network meta-analysis
DiscussionThe review is anticipated to provide up to date evidence for further studies and clinic practices regarding glycaemic control, hypoglycaemia, and hyperglycaemia issues. The results will be published in a peer-reviewed journal.Trial registrationPROSPEROCRD42020188399.
Source: Systematic Reviews - June 2, 2022 Category: International Medicine & Public Health Source Type: research
